Parkinson Disease — Biomarker Assessments of Leukine During Treatment of Parkinson's Disease
Citation(s)
Safety, Tolerability and Biomarker Assessments of Leukine (Sargramostim) During Extended Timed Treatment for Parkinson's Disease: A Phase I Pilot Study